Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amuza is a private life science tools company focused on neuroscience and broader biomedical research instrumentation. The company supplies and supports commercial research products including microdialysis systems, HPLC-ECD neurotransmitter analysis instruments, wireless optogenetics, wireless fiber photometry, wireless EEG systems, behavioral neuroscience equipment, tissue clearing tools, and selected cell biology and laboratory products. Amuza positions itself as a research partner rather than a therapeutics developer, working closely with academic and laboratory customers to configure instruments and support experimental workflows. The company traces its U.S. operating history to Eicom USA and formally adopted the Amuza name while continuing to distribute Eicom products alongside its own branded neuroscience tools. Its business appears centered on commercialization and distribution across North and South America rather than drug discovery or clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amuza.